Exact Sciences Corporation
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Exact Sciences Corporation sits in the top decile of US sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count).
Exact Sciences Corporation: 30 sponsored US clinical trials, 3 recruiting.
Exact Sciences Corporation sponsors 30 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 19 completed. The most-studied condition in this pipeline is Colorectal Cancer, with 4 trials.
Top-decile sponsor footprint
Exact Sciences Corporation ranks in the top decile of sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
19 of 24 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
30 total, page 1 of 1
Endometrial Cancer Vaginal Fluid Specimen Collection Study
NCT07544680
Falcon Real World Evidence Registry
NCT06589310
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
NCT06401421
CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer
NCT05210283
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
NCT05064553
Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality
NCT04124406
Informed Choice - Compass
NCT05246839
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01
NCT04473625
Home Usability Study of the SARS-CoV-2 (COVID-19) Test
NCT04395391
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
NCT04213326
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"
NCT04144738
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
NCT04144751
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
NCT03727087
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
NCT03821948
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
NCT03789162
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
NCT03727009
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
NCT03741166
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
NCT03728348
Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)
NCT03705013
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
NCT03662204
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
NCT03628651
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
NCT03628638
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
NCT03633006
A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval
NCT02419716
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
NCT02503631
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
NCT02503696
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
NCT01819766
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
NCT01600209
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
NCT01397747
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
NCT01260168
Therapeutic Areas
What is open in the Exact Sciences Corporation pipeline
3 recruiting of 30 indexed (10% open); 19 completed (63%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Colorectal Cancer (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Exact Sciences Corporation: open-pipeline peers nationwide
Peers matched on 30 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Exact Sciences Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 30 trials (± recruiting share)
- Biotronik · 30 trials · 3% recruiting
- Charles Drew University of Medicine and Science · 30 trials · 3% recruiting
- Chiesi Farmaceutici S.p.A. · 30 trials · 13% recruiting
- Debiopharm International · 30 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Abiomed · 10% recruiting · 20 trials
- Aimmune Therapeutics · 10% recruiting · 10 trials
- Altria Client Services · 10% recruiting · 10 trials
- Alzheimer's Disease Cooperative Study (ADCS) · 10% recruiting · 10 trials
Related
What to do with this Exact Sciences Corporation page
30 registered trials is a research-attention snapshot, not an endorsement of Exact Sciences Corporation or any single study.
- 3 of Exact Sciences Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Colorectal Cancer is the condition Exact Sciences Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Colorectal Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Exact Sciences Corporation pipeline card: 30 registered trials from official public datasets.Report a data error.